Bellicum Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,167.60
191,601.60
94,061.00
103,772.00
98,896.00
92,999
Total Accounts Receivable
745.50
297.90
440.00
334.00
320.00
909
Other Current Assets
254.10
1,322.30
2,389.00
1,504.00
2,434.00
1,387
Total Current Assets
12,167.20
193,221.80
96,890.00
105,610.00
101,650.00
95,295
Net Property, Plant & Equipment
2,289.90
2,427.40
6,882.00
16,504.00
25,942.00
20,878
Total Investments and Advances
-
-
56,304.00
9,640.00
7,558.00
4,973
Other Assets
484.50
145.00
330.00
283.00
378.00
355
Total Assets
14,941.60
195,794.20
160,406.00
132,037.00
135,528.00
121,501
ST Debt & Current Portion LT Debt
400.00
-
13.00
1,808.00
31.00
Accounts Payable
549.60
1,209.00
2,106.00
3,623.00
3,287.00
Other Current Liabilities
1,254.80
2,427.10
5,326.00
9,682.00
8,838.00
Total Current Liabilities
2,204.40
3,636.10
7,445.00
15,113.00
12,156.00
Long-Term Debt
400.00
-
118.00
18,577.00
35,077.00
Other Liabilities
563.20
522.30
826.00
1,773.00
3,647.00
Total Liabilities
3,167.60
4,158.40
8,389.00
35,463.00
50,880.00
Common Equity (Total)
28,151.90
191,635.80
152,017.00
96,574.00
84,648.00
Total Shareholders' Equity
11,774.00
191,635.80
152,017.00
96,574.00
84,648.00
Total Equity
11,774.00
191,635.80
152,017.00
96,574.00
84,648.00
Liabilities & Shareholders' Equity
14,941.60
195,794.20
160,406.00
132,037.00
135,528.00
Preferred Stock (Carrying Value)
39,925.90
-
-
-
-
About Bellicum Pharmaceuticals
View Profile
